Recently, it was demonstrated that HLA-DMA, identified as a crucial TME-related gene in lung adenocarcinoma (LUAD), correlates positively with survival and may serve as a potential biomarker for immune infiltration and response to immunotherapy [37]. This evidence concerns the gene HLA-DMA and lung adenocarcinoma.